Tarperprumig
- Generic Name
- Tarperprumig
Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT05565092
- Locations
- 🇺🇸
Research Site, Indianapolis, Indiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath